Jill M. Jene
CIK 1742105 · VP, Business Development · last filed 2026-06-04
Jill M. Jene is a VP, Business Development who has filed 11 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for LPCN, was dated Jun 4, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
11
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LPCN | Director | — | $2.26 | — | $0 | 6 | 2026-06-04 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | VP, Business Development | 194,805 | — | — | $0 | 5 | 2020-04-07 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2025-06-05 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2023-05-12 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2022-04-12 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2020-04-07 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +194,805 | $0 | EDGAR |
| 2020-01-10 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +194,805 | $0 | EDGAR |
| 2019-04-16 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-01 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | — | $0 | EDGAR |